verified SJR 1,585 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · Oxford University Press

workspace_premium Q1 — Pharmacology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

International Journal of Neuropsychopharmacology

International Journal of Neuropsychopharmacology is a journal indexed in SJR in Pharmacology and Psychiatry and Mental Health with an H index of 130. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1540 €. The scope of the journal is focused on neuropsychopharmacology, neuroimaging, neuropsychology, psychiatry, pharmacology, psychoneuroendocrinology. It has an SJR impact factor of 1,585 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,585.

International Journal of Neuropsychopharmacology focuses its scope in these topics and keywords: cocaine, depression, kinases, patients, serotonin, gateway, european, induced, antidepressant, availability, ...

ISSN: 1461-1457

Publisher: Oxford University Press

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,585 Q1

H-index 130

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

12 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.540 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,585

H-index

130

Docs (year)

Docs 3y

288

Total refs

3613

Cites 3y

1322

Citable 3y

279

Cites/Doc 2y

4.02

Ref/Doc

57.35

Immediate OA

1540 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Chronic lithium treatment affects rat brain and serum dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEA-S) levels

We are in the dark here: induction of depression- and anxiety-like behaviours in the diurnal fat sand rat, by short daylight or melatonin injections

Effects of sigma ligands on NMDA receptor function in the bulbectomy model of depression: a behavioural study in the rat

Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study

Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients

Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response

Effect of repeated treatment with olanzapine or olanzapine plus fluoxetine on tyrosine hydroxylase in the rat locus coeruleus

Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia

Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment

Do antidepressants help much in comparison to placebo?

Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour

Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs

SHOW MORE ARTICLES

Chronic rTMS induces subsensitivity of post-synaptic 5-HT1A receptors in rat hypothalamus

A case of clarithromycin-induced manic episode (antibiomania)

Chromium treatment of depression

Changes in the IJNP Editorial Board

Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat

Basal activity of the HPA axis and cognitive function in anorexia nervosa

Augmentation of milnacipran by risperidone in treatment for major depression

Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up

An autoradiographic study of the influence of pindolol upon [35S]GTP gammaS binding in rat, guinea pig and human brain

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders

Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation

Age- and region-dependent alterations in the GABAergic innervation in the brain of rats treated with amphetamine

FAQs

International Journal of Neuropsychopharmacology has an SJR of 1,585 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 1540 EUR.

The acceptance rate recorded for International Journal of Neuropsychopharmacology is 23%.

International Journal of Neuropsychopharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of International Journal of Neuropsychopharmacology?

What is the APC / publication cost?

What is the acceptance rate?